The Chart for Spruce Biosciences Inc. (SPRB) Is Flashing Mixed Signals – News Heater
Home  »  Companies   »  The Chart for Spruce Biosciences Inc. (SPRB) Is Fl...

The Chart for Spruce Biosciences Inc. (SPRB) Is Flashing Mixed Signals

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Spruce Biosciences Inc. (NASDAQ:SPRB) went up by 5.66% from its latest closing price compared to the recent 1-year high of $35.60. The company’s stock price has collected -9.97% of loss in the last five trading sessions. Press Release reported on 11/18/21 that Spruce Biosciences to Participate in the Piper Sandler 33(rd) Annual Healthcare Conference

Is It Worth Investing in Spruce Biosciences Inc. (NASDAQ :SPRB) Right Now?

Opinions of the stock are interesting as 3 analysts out of 5 who provided ratings for Spruce Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $17.60, which is $8.2 above the current price. SPRB currently public float of 4.16M and currently shorts hold a 11.52% ratio of that float. Today, the average trading volume of SPRB was 104.12K shares.

SPRB’s Market Performance

SPRB stocks went down by -9.97% for the week, with a monthly drop of -38.86% and a quarterly performance of -62.67%, while its annual performance rate touched -89.18%. The volatility ratio for the week stands at 7.76% while the volatility levels for the past 30 days are set at 8.54% for Spruce Biosciences Inc.. The simple moving average for the period of the last 20 days is -31.45% for SPRB stocks with a simple moving average of -75.52% for the last 200 days.

Analysts’ Opinion of SPRB

H.C. Wainwright, on the other hand, stated in their research note that they expect to see SPRB reach a price target of $30. The rating they have provided for SPRB stocks is “Buy” according to the report published on July 19th, 2021.

Credit Suisse gave a rating of “Outperform” to SPRB, setting the target price at $26 in the report published on April 26th of the current year.

SPRB Trading at -43.85% from the 50-Day Moving Average

After a stumble in the market that brought SPRB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.13% of loss for the given period.

Volatility was left at 8.54%, however, over the last 30 days, the volatility rate increased by 7.76%, as shares sank -37.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -61.22% lower at present.

During the last 5 trading sessions, SPRB fell by -9.97%, which changed the moving average for the period of 200-days by -87.62% in comparison to the 20-day moving average, which settled at $4.00. In addition, Spruce Biosciences Inc. saw -88.48% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SPRB starting from SIMPSON CAMILLA V, who sale 334 shares at the price of $15.29 back on May 20. After this action, SIMPSON CAMILLA V now owns 0 shares of Spruce Biosciences Inc., valued at $5,107 using the latest closing price.

Novo Holdings A/S, the 10% Owner of Spruce Biosciences Inc., sale 475,000 shares at $13.90 during a trade that took place back on May 19, which means that Novo Holdings A/S is holding 4,514,336 shares at $6,602,500 based on the most recent closing price.

Stock Fundamentals for SPRB

The total capital return value is set at -37.37, while invested capital returns managed to touch -38.52. Equity return is now at value -30.70, with -27.80 for asset returns.

Based on Spruce Biosciences Inc. (SPRB), the company’s capital structure generated 4.27 points at debt to equity in total, while total debt to capital is 4.09. Total debt to assets is 3.92, with long-term debt to equity ratio resting at 2.39. Finally, the long-term debt to capital ratio is 2.29.

>> 7 Top Picks for the Post-Pandemic Economy <<

The liquidity ratio also appears to be rather interesting for investors as it stands at 16.43.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam